The methods we’ve traditionally used to tell if you have heart disease aren’t very accurate. Only 40% of people who have a heart attack experience any warning signs like chest pain of shortness of breath. Cholesterol levels, inflammation levels, diabetes status, blood pressure, etc. are only indirect markers– highly unreliable in identifying who has heart disease and who's at risk of a heart attack.

Our guest on the show today is here to tell us about a better way to identify heart disease and save lives. Dr. James Min is a board certified cardiologist and professor of radiology and medicine at Cornell. He’s also the founder of Cleerly, a company that provides 3D images of the coronary system so that doctors can see exactly what’s going on and what exactly a specific patient needs.

Dr. James Min is on a mission to create a world without heart attacks. What he has to say is fascinating.

The Biggest Helping: Today’s Most Important Takeaway

Heart disease remains, is, was, and remains the number one public health epidemic in the world. There's somebody who suffers a heart attack in the US every 40 seconds. It's a preventable phenomenon. We have a heavy toolbox of tools. We just need to identify people at an early stage where we can get to them, treat them effectively and prevent all of these catastrophic events from occurring. It's a new paradigm, a new clinical paradigm, but I think it is the one that has been demonstrated in many other fields to be successful. And I think what we need to do is really introduce or transition our field into an era of precision heart care or personalized medicine. So easy to be proactive. It's harder to be reactive because an adverse event has already occurred.

--

Thank you for joining us on The Daily Helping with Dr. Shuster. Subscribe to the show on Apple Podcasts and Spotify to download more food for the brain, knowledge from the experts, and tools to win at life.

Resources:

• Find a Cleerly-integrated scan site near you
• Learn more at CleerlyHealth.com

Produced by NOVA Media